INTRODUCTION
A rare disease is any disease that affects a small percentage of the population. In the European Union, a disease is defined as rare when it affects less than 1 in 2,000 people. The number of the rare diseases is estimated to be about 7,000-8,000 and 1,139 of them have been characterized as recessive. Approximately 80% have a defined genetic basis. Despite low frequency of diseases, because of their great number, even 30 million European Union citizens may be affected by rare diseases (1, 2) . Considering this, research of these diseases has great importance and study of them may help to explain the mechanisms of diseases and help to develop more advanced diagnostics.
Classical strategies to identify the cause of Mendelian diseases rely on using linkage analysis, homozygosity mapping, and association analysis.
Linkage analysis is family-based approach that was a great tool for Mendelian disease discovery and has a relatively long history of successful detection of the rare Mendelian diseases such as Huntington's disease and cystic fibrosis (3) . However, some of the rare Mendelian diseases can be caused by multiple genetic variants as well as by new de novo mutations which, according to Vissers (4) , can be linked to 7 of 10 patients of mental disability -in these cases linkage analysis is not effective.
Autozygosity mapping has been a good method for the identification of the autosomal recessive disease genes. However, that approach is limited by the unavailability of suitable consanguineous families' genealogies. While rare autosomal recessive diseases are overrepresented in consanguineous families, a significant proportion of affected patients nonetheless originate in families where the parents are apparently unrelated (5) . So, even if there is a successful history of the rare disease identification with classical approaches, it encounters with problems like multiple genetic variants, de novo mutations, extremely rare cases that make these strategies not enough suitable for disease study. A new turning point was appearance of the next-generation sequencing (NGS) technologies.
NGS technologies are a powerful tool for identification of genetic disease causes. These technologies enable the whole genome and exome sequencing to avoid homozygosity mapping, prioritize candidate genes and to proceed directly to the examination of the list of variants. That gives enough insight to "pinpoint" the mutation responsible for a disease. At present several national projects using NGS are released in Canada, Korea, UK, USA, and other countries (6, 7) .
Disease gene identification challenge using NGS technology changes to interpretation challenge, because using it researchers obtain a sizeable amount of variation data that must be thoroughly filtered. This part of NGS is the most difficult one and requires efficient tools for filtering and interpreting results of sequencing (8) .
Most of published whole genome studies have been focused mainly on the coding part, which is only about 1.5 percent of the whole genome, because of knowledge that roughly 85% of the known genetic causes of Mendelian disorders affect the protein coding regions (8, 9) . The term 'exome' can be defined as a coding part of genome -all exons.
Whole exome sequencing (WES) is an effective strategy for selective sequencing of only coding regions of genome (9) . Advantage using WES is because of two reasons: firstly, there are extremely rare diseases with only few affected individuals and families per disorder, which result in underpowered analyses and / or large regions under the linkage peak(s); secondly, despite that these disorders are rare, the causal mutations show the large phenotypic effect (2, 8) .
Although many different methods for targeted capture have been described, only few have been extended to target the human exome. These highthroughput sequence capture methods are based on hybridization, for example, array-based hybridization or liquid-based hybridization depend on technology that is used (10) .
DISCUSSION
Initial exome sequencing was made by Sarah Ng and colleagues in 2009, when gene of the rare autosomal recessive genetic disorder, Miller syndrome, was found (11) . This new approach has opened a new revolutionary page of opportunities for the rare disease research and diagnostic. During brief 3 years of WES usage a considerably high number of novel recessive disease genes have been discovered. That includes all types of inheritable rare diseases -autosomal recessive, autosomal dominant, X-linked. WES allowed finding genes that have an autosomal dominant pattern in diseases such as Kabuki, Schinzel-Giedion, Hajdu-Cheney syndromes, paroxysmal kinesigenic dyskinesia, primary lymphoedema, high myopia, dilated cardiomyopathy, autism, and others (12) (13) (14) (15) (16) .
New X-linked disease causing genes such as TARP syndrome, leucoencephalopathy or Xlinked intellectual disability were also discovered (17) (18) (19) . Using exome sequencing technique mutations were found in mitochondrial DNA genes such as MRPL3 (mitochondrial cardiomyophathy) or AARS2 (infantile mitochondrial cardiomyophathy) (13, 20) . That shows a great impact of WES on rare disease diagnostics. The autosomal recessive diseases especially benefit from this new method, and this review concentrates on such diseases.
In diseases research, the best way to carry out research is by combining few methods. In case of rare diseases, many authors combine homozigosity mapping and exome sequencing. In disease studies, exome sequencing is used both as a basis research and as a way to confirm that gene mutation actually causes a disease. Combined use of exome sequencing and homozygosity mapping was applied in the study of Van Den Ende-Gupta syndrome, Joubert syndrome and other disorders (21) (22) (23) .
One of WES advantages is that disease genes may be identified using a very limited number of patients -they may be identified even from only one patient. For instance, polycystic kidney disease's genetical cause was identified from only one 5-year-old young boy who had this disease. With the help of exome sequencing, two heterozygous PKHD1 gene mutations were found, which lead to substitution of an asparagine for an aspartate, and that is the cause of disease. In this study, the researchers combined both, family and population, strategies (24) . Another example, a rare recessive FLVCR2 gene mutation that causes Fowler syndrome and is associated with progressive destruction of central nervous system tissue, was found out by testing only two patients (25) . Ability to identify disease causing genes by exome sequencing only from a single or small number of affected individuals has considerable importance, as some rare diseases are so rare that it is difficult to find enough patients for that disease research.
As it was mentioned, since November 2009, exome sequencing has led to significant progress of rare autosomal recessive Mendelian disease identification. In the Table, these diseases are divided into vision and hearing; skeletal, teeth and skin; ciliopathic; nervous system and neuromascular as well as immunological groups.
In a short period of time, WES made a huge impact on research of ciliopathies -an emerging class of human genetic disorders that is caused by defects in cilia. These defects in cilia are associated with a range of human diseases, such as primary ciliary dyskinesia, hydrocephalus, polycystic liver and kidney disease, and some forms of retinal degeneration (26) . Using WES, mutations that cause ciliopathy diseases were found: Van Den Ende-Gupta, Sensenbrenner, Joubert, Bardet-Biedl syndromes, Leber congenital amaurosis, polycystic kidney disease, primary ciliary dyskinesia (21) (22) (23) (24) (27) (28) (29) (30) (31) . Exome sequencing effectively confirmed that the nonsynonymous mutation chr22:19115386 C>T in the SCARF2 gene, which is expressed during development, is responsible for Van Den Ende-Gupta syndrome that affects multi-system (21) . Also there were studies where exome sequencing was applied to reveal genes causing Joubert syndrome -a neurological, ciliopathic disorder manifested by psychomotor retardation, hypotonia, and ataxia. In 2010, Edvardson (22) found mutation in the TMEM216 gene related to Joubert syndrome type 2 in Ashkenazi Jews, and in 2012 Srour (23) found other mutations in C5orf42 gene that also cause Joubert syndrome in the French Canadian population. An autosomal-recessive disease that is characterized by sagittal craniosynostosis and facial, ectodermal, and skeletal anomalies is known as Sensenbrenner syndrome. Gilissen and colleges (27) sequenced exomes of 2 patients and indentified compound heterozygous mutations in exon 2 of the WDR35 gene, causing Sensenbrenner syndrome. Another disease's gene related with ciliopathy and affecting multi-system was identified in 2012. This disease is Bardet-Biedl syndrome and it is caused by a homozygous 5 bp deletion in the LTZFL1 gene (28) . Whole-exome sequencing performed by 2 different scientist teams showed that NMNAT1 gene mutation is causing ciliopathic disease Leber congenital amaurosis (29, 30) . Polycystic kidney disease and primary ciliary dyskinesia are also ciliopathic diseases that were studied with the help of whole exome sequencing (24, 31) .
Exome sequencing also has some impact on vision and hearing diseases studies. Stargardt macular dystrophy, Leber congenital amaurosis and retinitis pigmentosa are diseases that are related with vision disorders and all of them were successfully analyzed by whole exome sequencing (29) (30) (32) (33) (34) . Stargardt macular dystrophy is an inheritable degeneration disease that causes progressive vision loss. Whole exome sequencing revealed 7 diseases likely causing variants across four genes, providing a confident genetic diagnosis in six previously uncharacterized participants. There were identified four previously missed mutations in the ABCA4 gene across three individuals. Also, mutations were identified in RDS/PRPH2, ELOVL, and CRB1 genes that are also likely to cause this disease (32) . Retinitis pigmentosa (RP) is a heterogeneous group of (33), and Züchner and his team's work with the Ashkenazi Jewish family, which showed that the DHDDS gene also harbors retinitis pigmentosa causing mutation (34) . Hearing diseases were also studied by exome sequencing including Usher, Perrault and Brown-Vialetto-van Laere syndromes, nonsyndromic hearing loss (11, (35) (36) (37) (38) (39) . Usher syndrome is a retinitis pigmentosa syndromic form when a patient not only has a condition of vision loss, but also has hearing loss. With the help of homozygosity mapping and next-generation targeted exons sequencing in the Lebanese family which has Usher syndrome type 3 phenotype, causative mutation was found in AB-HD12 gene (35) . Perrault and Brown-Vialetto-van Laere syndromes are two more examples of hearing disorders investigated by exome sequencing. With the help of WES causative mutation in Perrault syndrome was identified in the HSD17B4 gene (36) , and in Brown-Vialetto-van Laere syndrome such mutation was revealed in the SLC52A3 gene (37) (38) . Nonsyndromic hearing loss was also studied using WES (39) .
WES also allowed finding disease genes whose products are functioning in mitochondria, but are encoded by nuclear genes. Such situation was determined for the RRM2B gene, associated with autosomal recessive progressive external ophthalmoplegia. The RRM2B gene encodes a small subunit of ribonucleotide reductase small 2-like protein p53R2 which plays the essential role in the maintenance of mtDNA (40) .
With the aid of WES, many diseases that affect bones, teeth and skin were studied. That includes skeletal dysplasia, 3-M syndrome, osteogenesis imperfecta, chondrodysplasia and abnormal joint development, Miller syndrome -bone dis eases; amelogenesis imperfecta, Kohlschütter-Tönz syndrome -teeth diseases; as well as skin diseases -peeling skin syndrome, Kaposi's sarcoma (11, (41) (42) (43) (44) (45) (46) (47) (48) . Skeletal dysplasia, that commonly is called dwarfism, is a group of disorders characterized by abnormalities of cartilage and bone growth. When whole-exome sequencing was applied to a family of two healthy parents and two affected child ren with skeletal dysplasia, two novel compound heterozygous loss-of-function mutations in the POP1 gene were found and identified as disorder causative mutations (41) . Another investigation using WES related with skeletal dysplasia was held by Hanson et al. (42) . Mutation in the CCDC8 gene was idenfitied as a cause of 3-M syndrome that is known as a syndromic form of skeletal dysplasia. One more genetic bone disorder is osteogenesis imperfecta. Patients with such disorder have very easily breaking bones. With the help of WES, it was determined that four unrelated individuals had SERPINF1 gene mutations as an osteogenesis imperfecta cause (43) . As for teeth disease, amelogenesis imperfecta, characterized by abnormal enamel formation, and the related Kohlschütter-Tönz syndrome are examples of WES studied teeth diseases. Mutation in the FAM20A gene related with amelogenesis imperfecta (45) and the ROGDI gene mutation related with Kohlschütter-Tönz syndrome were found (46) . One of successful examples for WES applying to the skin diseases is peeling skin syndrome, genetic disorder characterized by continual peeling of the skin. By homozygosity mapping and whole-exome sequencing a novel homozygous missense mutation was identified within the the CHST8 gene (47) . Another example is finding that the gene STIM1 is related with Kaposi's sarcoma, which is skin cancer (48) .
An important disorder group represents diseases that cause damage of the nervous system. In this category the whole-exome sequencing also keeps pace with other disorder groups and there is already not significant number of diseases inheritable in autosomal recessive or dominant manner and studied using WES. As for recessive diseases causing damage in the central nervous system and studied by WES, nonsyndromic mental retardation and hyperphosphatasia mental retardation syndrome are fine examples (49, 50) . In these both diseases damage of CNS causes mental retardation. In 2011 using WES, Caliskan and colleagues found that mutation in the TECR gene causes nonsyndromic mental retardation (49). Krawitz using WES performed an exhaustive inquiry of hyperphosphatasia mental retardation syndrome and found mutations in two genes PIGV and PIGO causing this disease (50) . Disorders related with ataxia were also studied with the help of WES. Ataxia deve lops as a consequence of cerebellum degeneration responsible for control of muscle coordination. With the aid of WES, different ataxia types were investigated -congenital cerebellar ataxia that is caused by mutation in the GRM1 gene, infantile onset spinocerebellar ataxia caused by mutation in the C10orf2 gene and spinocerebellar ataxia with psychomotor retardation caused by SYT14 gene's mutation (51) (52) (53) . Previously mentioned progressive external ophthalmoplegia as well as lethal congenital contractural type 4 and Fowler syndromes also belong to the nervous system diseases group analyzed with WES (25, 40, 54) .
Refering to autosomal recessive manner inheritable immunological diseases studied by whole-exome sequencing, autoimmune lymphoproliferative syndrome and aplastic anemia could be mentioned. Autoimmune lymphoproliferative syndrome is an immune system disorder characterised by too large number of lymphocytes production followed by numerous autoimmune problems. Previously it was known that FASL and FAS gene mutations cause this disorder, but with combination of whole-exome sequencing and genome-wide linkage analysis it was shown that lymphoproliferative syndrome also develops after mutation in the FADD gene (55). Another disease, aplastic anemia, when bone marrow fails to make enough blood cells, was studied using exome sequencing in the Tunisian family with 2 affected children. In both patients with aplastic anemia, the sequencing data showed the c.1248 G>A mutation in the MPL gene (56).
CONCLUSIONS
In conclusion, the whole-exome sequencing, during its short period of existing (three years), was successfully applied to many different rare autosomal recessive diseases. Such variety of diseases studied by WES are referred to in the present review. The number of studied diseases is further growing very fast; therefore WES will take an important place in rare disorders research. Further using of wholeexome sequencing and fast increasing information on the rare diseases allow prognosticating a wide application of WES in population studies. 
GENŲ, LEMIANČIŲ RETAS AUTOSOMINES RECESYVINES LIGAS, TYRIMŲ REZULTATAS PAGAL EGZOMO SEKOSKAITĄ

Santrauka
Reta laikoma ta liga, kuria serga tik nedidelė populiacijos dalis. Europos Sąjungoje reta liga laikoma tada, kai ja serga mažiau nei 1 iš 2 000 žmonių. Ir nors nuo vienos retos ligos kenčia nedaug žmonių, tokių retų ligų yra daug. Manoma, kad tokio pobūdžio ligų yra apie 7 000-8 000. Tad vien Europos Sąjungoje tokiomis ligomis sergančių asmenų priskaičiuojama per 30 milijonų. Toks didelis sergančių asmenų skaičius verčia domėtis ir tirti retas ligas, ir tai gali padėti išaiškinti šių ligų atsiradimo priežastis bei sukurti naujus, tobulesnius jų diagnozavimo būdus. Klasikinės paveldimų ligų tyrimo strategijos susiduria su papildomomis problemomis (dauginiai genetiniai variantai, de novo mutacijos, ypač reti atvejai), ir tai daro šias strategijas nepakankamai veiksmingas. Naujos kartos sekoskaita atveria naują retų ligų tyrimų puslapį. Viso egzomo sekoskaita per trumpą gyvavimo laikotarpį sugebėjo nemažai prisidėti ieškant retų autosominių recesyvinių ligų genetinių priežas-čių -per trejus metus buvo aptikta ir ištirta daug naujų mutacijų genuose, lemiančių šias ligas. Raktažodžiai: retos autosominės recesyvinės ligos, viso egzomo sekoskaita, sindromai
